Deals
Icahn Wins One Board Seat in Illumina Proxy Fight
- Andrew Teno set to join DNA-sequencing company’s board
- Activist investor had sought three board seats at Illumina
Carl Icahn
Photographer: Mat Szwajkos/Getty Images North AmericaThis article is for subscribers only.
Illumina Inc. shareholders voted to elect a board member nominated by activist shareholder Carl Icahn, a much-needed partial victory for the billionaire as his investment firm grapples with an attack by short-seller Hindenburg Research.
Andrew Teno, a portfolio manager at Icahn Capital, will join Illumina’s nine-person board as a director, the company said in a statement Thursday. Teno, one of Icahn’s three nominees, replaces Chairman John Thompson, who had been on Illumina’s board since 2021.